vs
艾伯维（ABBV）与Envista Holdings Corp（NVST）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Envista Holdings Corp的22.1倍（$16.6B vs $750.6M）。艾伯维净利率更高（10.9% vs 4.4%，领先6.5%）。Envista Holdings Corp同比增速更快（15.0% vs 10.0%）。艾伯维自由现金流更多（$4.9B vs $91.7M）。过去两年艾伯维的营收复合增速更高（16.2% vs 9.7%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
Envista Holdings Corp是一家总部位于美国的企业，旗下Envista Forensics业务板块面向保险、法律及风险管理行业，在全球范围内提供法务工程与事故复原解决方案。公司前身为LWG咨询有限公司，2017年正式更名为Envista Forensics。
ABBV vs NVST — 直观对比
营收规模更大
ABBV
是对方的22.1倍
$750.6M
营收增速更快
NVST
高出4.9%
10.0%
净利率更高
ABBV
高出6.5%
4.4%
自由现金流更多
ABBV
多$4.8B
$91.7M
两年增速更快
ABBV
近两年复合增速
9.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $750.6M |
| 净利润 | $1.8B | $32.9M |
| 毛利率 | 72.6% | 54.7% |
| 营业利润率 | 27.3% | 9.8% |
| 净利率 | 10.9% | 4.4% |
| 营收同比 | 10.0% | 15.0% |
| 净利润同比 | 8354.5% | 2641.7% |
| 每股收益（稀释后） | $1.02 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVNVST
| Q4 25 | $16.6B | $750.6M | ||
| Q3 25 | $15.8B | $669.9M | ||
| Q2 25 | $15.4B | $682.1M | ||
| Q1 25 | $13.3B | $616.9M | ||
| Q4 24 | $15.1B | $652.9M | ||
| Q3 24 | $14.5B | $601.0M | ||
| Q2 24 | $14.5B | $633.1M | ||
| Q1 24 | $12.3B | $623.6M |
净利润ABBVNVST
| Q4 25 | $1.8B | $32.9M | ||
| Q3 25 | $186.0M | $-30.3M | ||
| Q2 25 | $938.0M | $26.4M | ||
| Q1 25 | $1.3B | $18.0M | ||
| Q4 24 | $-22.0M | $1.2M | ||
| Q3 24 | $1.6B | $8.2M | ||
| Q2 24 | $1.4B | $-1.2B | ||
| Q1 24 | $1.4B | $23.6M |
毛利率ABBVNVST
| Q4 25 | 72.6% | 54.7% | ||
| Q3 25 | 66.4% | 55.3% | ||
| Q2 25 | 71.8% | 54.2% | ||
| Q1 25 | 70.0% | 54.5% | ||
| Q4 24 | 70.9% | 57.1% | ||
| Q3 24 | 70.9% | 52.8% | ||
| Q2 24 | 70.9% | 51.6% | ||
| Q1 24 | 66.7% | 57.1% |
营业利润率ABBVNVST
| Q4 25 | 27.3% | 9.8% | ||
| Q3 25 | 12.1% | 8.6% | ||
| Q2 25 | 31.7% | 6.8% | ||
| Q1 25 | 28.0% | 6.3% | ||
| Q4 24 | -9.9% | 7.1% | ||
| Q3 24 | 26.5% | 3.5% | ||
| Q2 24 | 27.6% | -182.2% | ||
| Q1 24 | 22.7% | 7.7% |
净利率ABBVNVST
| Q4 25 | 10.9% | 4.4% | ||
| Q3 25 | 1.2% | -4.5% | ||
| Q2 25 | 6.1% | 3.9% | ||
| Q1 25 | 9.6% | 2.9% | ||
| Q4 24 | -0.1% | 0.2% | ||
| Q3 24 | 10.8% | 1.4% | ||
| Q2 24 | 9.5% | -181.9% | ||
| Q1 24 | 11.1% | 3.8% |
每股收益（稀释后）ABBVNVST
| Q4 25 | $1.02 | $0.20 | ||
| Q3 25 | $0.10 | $-0.18 | ||
| Q2 25 | $0.52 | $0.16 | ||
| Q1 25 | $0.72 | $0.10 | ||
| Q4 24 | $-0.03 | $0.00 | ||
| Q3 24 | $0.88 | $0.05 | ||
| Q2 24 | $0.77 | $-6.69 | ||
| Q1 24 | $0.77 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | $1.2B |
| 总债务越低越好 | $58.9B | $1.4B |
| 股东权益账面价值 | $-3.3B | $3.1B |
| 总资产 | $134.0B | $5.7B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资ABBVNVST
| Q4 25 | $5.3B | $1.2B | ||
| Q3 25 | $5.7B | $1.1B | ||
| Q2 25 | $6.5B | $1.1B | ||
| Q1 25 | $5.2B | $1.1B | ||
| Q4 24 | $5.6B | $1.1B | ||
| Q3 24 | $7.3B | $991.3M | ||
| Q2 24 | $13.2B | $1.0B | ||
| Q1 24 | $18.1B | $948.5M |
总债务ABBVNVST
| Q4 25 | $58.9B | $1.4B | ||
| Q3 25 | $63.0B | $1.4B | ||
| Q2 25 | $63.0B | $1.4B | ||
| Q1 25 | $64.5B | $1.4B | ||
| Q4 24 | $60.3B | $1.4B | ||
| Q3 24 | $58.5B | $1.4B | ||
| Q2 24 | $58.0B | $1.5B | ||
| Q1 24 | $63.8B | $1.5B |
股东权益ABBVNVST
| Q4 25 | $-3.3B | $3.1B | ||
| Q3 25 | $-2.6B | $3.1B | ||
| Q2 25 | $-183.0M | $3.1B | ||
| Q1 25 | $1.4B | $3.0B | ||
| Q4 24 | $3.3B | $2.9B | ||
| Q3 24 | $6.0B | $3.1B | ||
| Q2 24 | $6.8B | $3.0B | ||
| Q1 24 | $8.0B | $4.1B |
总资产ABBVNVST
| Q4 25 | $134.0B | $5.7B | ||
| Q3 25 | $133.9B | $5.6B | ||
| Q2 25 | $137.2B | $5.7B | ||
| Q1 25 | $136.2B | $5.5B | ||
| Q4 24 | $135.2B | $5.4B | ||
| Q3 24 | $143.4B | $5.5B | ||
| Q2 24 | $141.9B | $5.4B | ||
| Q1 24 | $148.9B | $6.6B |
负债/权益比ABBVNVST
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | 45.44× | 0.47× | ||
| Q4 24 | 18.15× | 0.48× | ||
| Q3 24 | 9.70× | 0.46× | ||
| Q2 24 | 8.56× | 0.51× | ||
| Q1 24 | 7.97× | 0.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $108.0M |
| 自由现金流经营现金流 - 资本支出 | $4.9B | $91.7M |
| 自由现金流率自由现金流/营收 | 29.4% | 12.2% |
| 资本支出强度资本支出/营收 | 2.0% | 2.2% |
| 现金转化率经营现金流/净利润 | 2.87× | 3.28× |
| 过去12个月自由现金流最近4个季度 | $17.8B | $230.4M |
8季度趋势，按日历期对齐
经营现金流ABBVNVST
| Q4 25 | $5.2B | $108.0M | ||
| Q3 25 | $7.0B | $78.7M | ||
| Q2 25 | $5.2B | $88.7M | ||
| Q1 25 | $1.6B | $300.0K | ||
| Q4 24 | $7.0B | $132.4M | ||
| Q3 24 | $5.4B | $70.7M | ||
| Q2 24 | $2.3B | $93.1M | ||
| Q1 24 | $4.0B | $40.3M |
自由现金流ABBVNVST
| Q4 25 | $4.9B | $91.7M | ||
| Q3 25 | $6.6B | $67.9M | ||
| Q2 25 | $4.9B | $76.4M | ||
| Q1 25 | $1.4B | $-5.6M | ||
| Q4 24 | $6.8B | $123.8M | ||
| Q3 24 | $5.2B | $63.3M | ||
| Q2 24 | $2.0B | $86.3M | ||
| Q1 24 | $3.8B | $29.3M |
自由现金流率ABBVNVST
| Q4 25 | 29.4% | 12.2% | ||
| Q3 25 | 42.1% | 10.1% | ||
| Q2 25 | 31.7% | 11.2% | ||
| Q1 25 | 10.5% | -0.9% | ||
| Q4 24 | 44.7% | 19.0% | ||
| Q3 24 | 35.9% | 10.5% | ||
| Q2 24 | 14.0% | 13.6% | ||
| Q1 24 | 31.3% | 4.7% |
资本支出强度ABBVNVST
| Q4 25 | 2.0% | 2.2% | ||
| Q3 25 | 2.4% | 1.6% | ||
| Q2 25 | 1.7% | 1.8% | ||
| Q1 25 | 1.8% | 1.0% | ||
| Q4 24 | 1.9% | 1.3% | ||
| Q3 24 | 1.7% | 1.2% | ||
| Q2 24 | 1.7% | 1.1% | ||
| Q1 24 | 1.6% | 1.8% |
现金转化率ABBVNVST
| Q4 25 | 2.87× | 3.28× | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | 3.36× | ||
| Q1 25 | 1.27× | 0.02× | ||
| Q4 24 | — | 110.33× | ||
| Q3 24 | 3.49× | 8.62× | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | 1.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABBV
暂无分部数据
NVST
| Other | $375.8M | 50% |
| Specialty Productsand Technologies | $188.4M | 25% |
| Equipmentand Consumables | $186.4M | 25% |
